Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Véronique Ferrand"'
Autor:
Judith Fischer, Bakar Bouadjar, Gianluca Tadini, Véronique Ferrand, André Mégarbané, Jean François Prud'homme, Mark Lathrop, Caroline Lefèvre
Publikováno v:
Human Molecular Genetics. 15:767-776
We report the identification of mutations in a non-syndromic autosomal recessive congenital ichthyosis (ARCI) in a new gene mapping within a previously identified locus on chromosome 19p12-q12, which has been defined as LI3 in the OMIM database (MIM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd535c3444c11c9ecffe544fd06ef7f4
https://doi.org/10.1093/hmg/ddi491
https://doi.org/10.1093/hmg/ddi491
Publikováno v:
Journal of Medical Virology. 70:131-136
X-linked lymphoproliferative disease is a rare inherited immunodeficiency in which affected males present abnormal responses to Epstein-Barr virus (EBV) infection. The gene defective in X-linked lymphoproliferative disease, SH2D1A (also named SAP or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a6831549c378c10af841318eb71c89
https://doi.org/10.1002/jmv.10373
https://doi.org/10.1002/jmv.10373
Autor:
Alain Daban, Hugues Bourgeois, Thierry Germain, Isabelle Billiart, Véronique Ferrand, Stéphanie Chieze, Jean-Marc Tourani, Jean-Claude Meurice, Virginie Chabrun, David Lemerre
Publikováno v:
American journal of clinical oncology. 27(1)
Gemcitabine (G) and cisplatin (P) are active reference agents in patients with non-small-cell lung cancer (NSCLC). Ifosfamide (I) has also been approved for NSCLC treatment. This phase I trial aimed to determine the dose-limiting toxicity (DLT), maxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cf959c17e3024d6b2bc4c51e90de797
https://pubmed.ncbi.nlm.nih.gov/14758140
https://pubmed.ncbi.nlm.nih.gov/14758140
Publikováno v:
Journal of Medical Virology; May2003, Vol. 70 Issue 1, p131-136, 6p